Our data have provided the cellular mechanisms underlying the activation of immune responses after Eg5 inhibition, which is helpful to clarify the pathogenesis in microcephaly, primary lymphedema, and chorioretinal dysplasia syndrome of the patients with Eg5 mutations. The gene discussed is KIF11; the disease is primary lymphedema.